Ani Pharmaceuticals Inc · Operating Cash Flow (Statement)

Latest reported$189.47Mperiod endingJun 30, 2026

ANIP Cash from Operations (-$3.04M → $189.47M)

Annual operating cash flow (statement)

High-resolution chart · PNG

ANIP operating cash flow (statement) history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Ani Pharmaceuticals Inc Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period ending	Operating Cash Flow (Statement) (USD)
Dec 31, 2025	185,225,000
Dec 31, 2024	64,017,000
Dec 31, 2023	118,959,000
Dec 31, 2022	-31,203,000
Dec 31, 2021	3,322,000
Dec 31, 2020	15,267,000
Dec 31, 2019	45,631,000
Dec 31, 2018	67,074,000
Dec 31, 2017	39,419,000
Dec 31, 2016	27,472,000
Dec 31, 2015	17,264,000
Dec 31, 2014	22,033,000
Dec 31, 2013	-5,484,000
Dec 31, 2012	-25,283,020
Dec 31, 2011	-47,870,103
Dec 31, 2010	-40,097,506
Dec 31, 2009	-18,430,910
Dec 31, 2008	-15,535,932
Dec 31, 2007	739,992
Dec 31, 2006	-4,996,735
Dec 31, 2005	-8,297,509
Dec 31, 2004	-10,442,443
Dec 31, 2003	-5,521,992
Dec 31, 2002	-3,962,493
Dec 31, 2001	-1,823,820
Dec 31, 2000	-3,207,604
Dec 31, 1999	-1,787,822
Dec 31, 1998	-3,041,425